Jumping into the vaccine gold mine... or landmine?


In July, the government had agreed for the facilities owned by Pharmaniaga Bhd and Duopharma Biotech Bhd to be used for the fill and finish process of the Covid-19 vaccine.

THE latest buzzword in the market now is vaccine, amid all the fanfare surrounding rubber glove makers who have been enjoying a spectacular run in the coronavirus disease (Covid-19) race.

If there is something that will stop the dominance of rubber gloves in their tracks it will have to be the development of a vaccine.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

vaccine , distribution , Duopharma , NRPA , Pharmaniaga , Covid-19 ,

   

Next In Business News

Australia's central bank holds rates, stays vigilant on inflation
Toyota to post first profit drop in 2 years as demand cools after big run
China's services activity picks up as conditions improve, Caixin PMI shows
Ringgit opens higher as US$ weakens post-NFP data
Bursa Malaysia drifts sideways as investors await start of US election
Trading ideas: SD Guthrie, Dayang, Datasonic, Elridge, Genetec, MN, Bina Puri, Bintai Kinden, MCE, BHIC, Carimin, Tuju Setia, Khee San
Wall St slips as uncertainty surrounds U.S. election
Oil jumps nearly 3% after Opec+ delays output hike, US election in focus
Datasonic acquires 51% stake in ICT firm
High real estate credit growth raises concern

Others Also Read